Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Janssen-Cilag Ltd
50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG
Telephone: +44 (0)1494 567 567
Fax: +44 (0)1494 567 568
WWW: http://www.janssen.co.uk
WWW: http://www.janssen-medinfo.co.uk
Medical Information Direct Line: +44 (0)800 731 8450
Medical Information e-mail: medinfo@janssen-cilag.co.uk
Customer Care direct line: +44 (0)800 731 5550

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 05/03/2012
PIL RISPERDAL CONSTA 25, 37.5 and 50 mg powder and solvent for prolonged-release suspension for intramuscular injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 05/03/2012 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 07/11/2011 and displayed until 05/03/2012
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to Further Information section
Updated on 07/04/2011 and displayed until 07/11/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 25/10/2010 and displayed until 07/04/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 28/06/2010 and displayed until 25/10/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
Updated on 18/01/2010 and displayed until 28/06/2010
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to packaging
  • Change to date of revision
  • Change to dosage and administration
Updated on 01/05/2009 and displayed until 18/01/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 10/12/2008 and displayed until 01/05/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 02/09/2008 and displayed until 10/12/2008
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 27/05/2008 and displayed until 02/09/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change due to user-testing of patient information
Updated on 27/11/2007 and displayed until 27/05/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 01/11/2007 and displayed until 27/11/2007
Reasons for adding or updating:
  • Change to how to administer the medicine
Updated on 27/07/2007 and displayed until 01/11/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 27/09/2006 and displayed until 27/07/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 14/03/2006 and displayed until 27/09/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 03/03/2006 and displayed until 14/03/2006
Reasons for adding or updating:
  • Change to how to administer the medicine
Updated on 05/04/2005 and displayed until 03/03/2006
Reasons for adding or updating:
  • Change of contra-indications
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 08/11/2004 and displayed until 05/04/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 03/09/2004 and displayed until 08/11/2004
Reasons for adding or updating:
  • Change of licence holder
Updated on 19/12/2002 and displayed until 03/09/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 13/08/2002 and displayed until 19/12/2002
Reasons for adding or updating:
  • New PIL for new product
Updated on 13/08/2002 and displayed until 13/08/2002
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  risperidone